Amoxycillin & Potassium Clavulanate Oral Suspension IP – Moxival CV 228.5 Suspension – 30ML

Moxival CV 228.5 Suspension – 30ML
Composition:- Amoxycillin 200 mg +Potassium Clavulanate 28.50 mg with water

Moxival CV 228.5 Suspension – 30ML – Amoxicillin & Potassium Clavulanate Oral Suspension IP is a pediatric-friendly, broad-spectrum antibiotic formulation. It combines Amoxicillin, a potent penicillin-class antibiotic, with Potassium Clavulanate, a β-lactamase inhibitor that enhances its efficacy against resistant bacteria.
It effectively treats mild to moderate bacterial infections of the respiratory tract, urinary tract, skin, and soft tissues. Clavulanate provides its complementary action for resistant strains (β-lactamase).

Key Points of Amoxycillin & Potassium Clavulanate Oral Suspension IP – Moxival CV 228.5 Suspension – 30ML

• Broad-Spectrum Activity – Combination shows its efficacy against both Gram-positive and Gram-negative bacteria and even against resistant bacteria.
• Beta-Lactamase Protection – Clavulanate provides additional benefit to amoxicillin by inhibiting resistant bacterial strains.
• Palatable Pediatric Form – Child-friendly taste and easy-to-administer suspension formulation.
• Rapid Action – Suspension provides its action rapidly to relieve infection symptoms.

Can be Prescribed by:

• Paediatricians
• ENT Specialists (Otolaryngologists)
• Pulmonologists
• General Physician
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.